helpdesk1

Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1 Foundayo, Lilly's second ...

Read more about FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

Health Net commits $1 million to public information effort to help eligible residents maintain Medi-Cal coverage under new federal and state ...

Read more about Medi-Cal Enrollees Prepare for New Community Engagement Requirements; Health Net Launches “Get Informed, Stay Covered” to Educate Members

Novel Transdermal Curcumin Formulation Demonstrates Pain Reduction and Improved Quality of Life in Phase 1b Clinical Trial Study published ...

Read more about Vascarta Announces Positive Clinical Trial Results for Topical/Transdermal Curcumin Gel VAS-101 in Knee Osteoarthritis

A right-sized all-electric entry SUV, delivering EV9-inspired design, practical range, and everyday usability to make electric mobility ...

Read more about THE ALL-NEW 2027 KIA EV3 DEBUTS AT NEW YORK INTERNATIONAL AUTO SHOW

New research and launch of proprietary AI-powered tool cements Egami as the multidimensional™ intelligence leader NEW YORK, April 1, 2026 ...

Read more about EGAMI GROUP LAUNCHES SEE ME MORE STUDY THAT SHOWS MULTICULTURAL CONSUMERS TRUST BRANDS WHO FOCUS ON MULTIPLE PARTS OF THEIR IDENTITY